相关实验视频

Updated: Jun 4, 2025

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

基于结构的Samaderin E和Bismurrayaquinone A植物化学物质的相互作用研究作为KRas基蛋白的潜在抑制剂

Z Hasan¹, M Y Areeshi², R K Mandal²

¹Department of Biosciences, Jamia Millia Islamia (Central University), New Delhi, India.

SAR and QSAR in environmental research

|January 2, 2025

概括

研究人员选了植物化学物质,以找到用于癌症治疗的KRas抑制剂. 萨马德林E和比斯穆拉亚金A通过结合KRas并改变其功能,显示出作为治疗剂的潜力.

科学领域:

在瘤学瘤学.
计算化学计算化学
药理学药理学是指药理学的学科.

背景情况:

拉斯蛋白是关键的瘤基因,在人类癌症中经常发生突变.
一种特定的异构体KRas是最常见的突变,导致细胞信号和生长不受控制.
抑制KRas是癌症治疗的一个关键策略.

研究的目的:

为了识别KRascoprotein的新型植物化学抑制剂.
分析潜在的KRas抑制剂的结合相互作用和机制.
评估已识别的植物化学品的治疗潜力.

主要方法:

从IMPPAT 2.0数据库中对11,698种植物化学物质进行基于结构的虚拟选.
对已确定化合物的结合模式和分子动力学 (MD) 模拟 (200 ns) 的详细分析.
计算分析包括RMSD,RMSF,Rg,SASA,键分析,二次结构分析,PCA和FEL分析.

主要成果:

两种植物化学物质,萨马德林E和比斯穆拉亚金A,被确定具有对KRas.有显著的结合亲和力.
这些化合物与KRas结合部位内的关键残留物 (ARG41和ASP54) 结合,诱导构造变化.
MD模拟和随后的分析证实了植物化学-KRas复合物的稳定性和相互作用机制.

结论:

萨马德林E和比斯穆拉亚金A显示出作为KRas基蛋白的有效治疗抑制剂的潜力.
已识别的植物化学物质与KRas上的功能口袋结合,为癌症药物开发提供了一个有前途的途径.
对这些化合物的进一步研究可能会导致新的KRas向癌症疗法.

关键词:

克拉斯克拉斯克拉斯克拉斯Kras 癌症癌症癌症癌症癌症分子对接的分子对接.分子动力学 (MD) 模拟.植物化学品植物化学品

更多相关视频

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...